Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Pharmaceuticals 산업에서 운영. 본사 소재지는 Nashville, DE, 미국. 현재 CEO는 Mark L. Baum.
HROWL 을(를) 보유 IPO 날짜 2021-05-07, 217 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $1.37B.
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
